Type II fatty acid synthesis is essential only for malaria parasite late liver stage development

Cellular Microbiology

Volumn 11, Issue 3, 2009, Pages 506-520

  Vaughan, Ashley M ^a   O'neill, Matthew T ^b   Tarun, Alice S ^a   Camargo, Nelly ^a   Phuong, Thuan M ^b   Aly, Ahmed S I ^a   Cowman, Alan F ^b   Kappe, Stefan H I ^a,c  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FATTY ACID 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICOPLAST; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FATTY ACID SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER; MALARIA; MEROZOITE; MOSQUITO; MOUSE; NONHUMAN; PLASMODIUM; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PRIORITY JOURNAL; PROKARYOTE; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RODENT; SPOROZOITE; UPREGULATION;

ANIMALS; BLOOD; ENZYMES; FATTY ACIDS; FEMALE; GENE DELETION; GENE KNOCKOUT TECHNIQUES; HUMANS; LIVER; MALARIA; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED BALB C; ORGANELLES; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PROKARYOTA; RODENTIA;

EID: 59849125892     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2008.01270.x     Document Type: Article

References (58)

1. Aly, A.S., Mikolajczak, S.A., Rivera, H.S., Camargo, N., Jacobs-Lorena, V., Labaied, M., et al. (2008) Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection. Mol Microbiol 69: 152-163.
2. Baer, K., Klotz, C., Kappe, S.H., Schnieder, T., and Frevert, U. (2007) Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 3: E171.
3. Bahl, A., Brunk, B., Crabtree, J., Fraunholz, M.J., Gajria, B., Grant, G.R., et al. (2003) PlasmoDB: The Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res 31: 212-215.
4. Bozdech, Z., Llinas, M., Pulliam, B.L., Wong, E.D., Zhu, J., and DeRisi, J.L. (2003) The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 1: E5.
5. Carlton, J.M., Angiuoli, S.V., Suh, B.B., Kooij, T.W., Pertea, M., Silva, J.C., et al. (2002) Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 419: 512-519.
6. Charoenvit, Y., Mellouk, S., Sedegah, M., Toyoshima, T., Leef, M.F., De la Vega, P., et al. (1995) Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody. Exp Parasitol 80: 419-429.
7. Cowman, A.F., and Crabb, B.S. (2006) Invasion of red blood cells by malaria parasites. Cell 124: 755-766.
8. Crabb, B.S., Rug, M., Gilberger, T.W., Thompson, J.K., Triglia, T., Maier, A.G., and Cowman, A.F. (2004) Transfection of the human malaria parasite Plasmodium falciparum. Methods Mol Biol 270: 263-276.
9. Daily, J.P., Scanfeld, D., Pochet, N., Le Roch, K., Plouffe, D., Kamal, M., et al. (2007) Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 450: 1091-1095.
10. van Dijk, M.R., Douradinha, B., Franke-Fayard, B., Heussler, V., van Dooren, M.W., van Schaijk, B., et al. (2005) Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci USA 102: 12194-12199.
11. Donelson, J.E. (2003) Antigenic variation and the African trypanosome genome. Acta Trop 85: 391-404.
12. van Dooren, G.G., Marti, M., Tonkin, C.J., Stimmler, L.M., Cowman, A.F., and McFadden, G.I. (2005) Development of the endoplasmic reticulum, mitochondrion and apicoplast during the asexual life cycle of Plasmodium falciparum. Mol Microbiol 57: 405-419.
13. Escalada, M.G., Russell, A.D., Maillard, J.Y., and Ochs, D. (2005) Triclosan-bacteria interactions: Single or multiple target sites? Lett Appl Microbiol 41: 476-481.
14. Ferguson, D.J., Campbell, S.A., Henriquez, F.L., Phan, L., Mui, E., Richards, T.A., et al. (2007) Enzymes of type II fatty acid synthesis and apicoplast differentiation and division in Eimeria tenella. Int J Parasitol 37: 33-51.
15. Ferguson, M.A., and Cross, G.A. (1984) Myristylation of the membrane form of a Trypanosoma brucei variant surface glycoprotein. J Biol Chem 259: 3011-3015.
16. Foth, B.J., Ralph, S.A., Tonkin, C.J., Struck, N.S., Fraunholz, M., Roos, D.S., et al. (2003) Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science 299: 705-708.
17. Foth, B.J., Stimmler, L.M., Handman, E., Crabb, B.S., Hodder, A.N., and McFadden, G.I. (2005) The malaria parasite Plasmodium falciparum has only one pyruvate dehydrogenase complex, which is located in the apicoplast. Mol Microbiol 55: 39-53.
18. Gardner, M.J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R.W., et al. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419: 498-511.
19. Gerold, P., Schofield, L., Blackman, M.J., Holder, A.A., and Schwarz, R.T. (1996) Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. Mol Biochem Parasitol 75: 131-143.
20. Goodman, C.D., Su, V., and McFadden, G.I. (2007) The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 152: 181-191.
21. Gornicki, P. (2003) Apicoplast fatty acid biosynthesis as a target for medical intervention in apicomplexan parasites. Int J Parasitol 33: 885-896.
22. Ishino, T., Chinzei, Y., and Yuda, M. (2005) Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte. Mol Microbiol 58: 1264-1275.
23. Jones, S.M., Urch, J.E., Kaiser, M., Brun, R., Harwood, J.L., Berry, C., and Gilbert, I.H. (2005) Analogues of thiolactomycin as potential antimalarial agents. J Med Chem 48: 5932-5941.
24. Kohler, S., Delwiche, C.F., Denny, P.W., Tilney, L.G., Webster, P., Wilson, R.J., et al. (1997) A plastid of probable green algal origin in apicomplexan parasites. Science 275: 1485-1489.
25. Krishnegowda, G., and Gowda, D.C. (2003) Intraerythrocytic Plasmodium falciparum incorporates extraneous fatty acids to its lipids without any structural modification. Mol Biochem Parasitol 132: 55-58.
26. Labaied, M., Harupa, A., Dumpit, R.F., Coppens, I., Mikolajczak, S.A., and Kappe, S.H. (2007) Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun 75: 3758-3768.
27. Lambros, C., and Vanderberg, J.P. (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418-420.
28. Le Roch, K.G., Zhou, Y., Blair, P.L., Grainger, M., Moch, J.K., Haynes, J.D., et al. (2003) Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301: 1503-1508.
29. Lee, S.H., Stephens, J.L., Paul, K.S., and Englund, P.T. (2006) Fatty acid synthesis by elongases in trypanosomes. Cell 126: 691-699.
30. McMurry, L.M., Oethinger, M., and Levy, S.B. (1998) Triclosan targets lipid synthesis. Nature 394: 531-532.
31. Maier, A.G., Braks, J.A., Waters, A.P., and Cowman, A.F. (2006) Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination. Mol Biochem Parasitol 150: 118-121.
32. Mazumdar, J., and Striepen, B. (2007) Make it or take it: Fatty acid metabolism of apicomplexan parasites. Eukaryot Cell 6: 1727-1735.
33. Mazumdar, J., Wilson, E.H., Masek, K., Hunter, C.A., and Striepen, B. (2006) Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii. Proc Natl Acad Sci USA 103: 13192-13197.
34. Menard, R., and Janse, C. (1997) Gene targeting in malaria parasites. Methods 13: 148-157.
35. Mi-Ichi, F., Kita, K., and Mitamura, T. (2006) Intraerythrocytic Plasmodium falciparum utilize a broad range of serum-derived fatty acids with limited modification for their growth. Parasitology 133: 399-410.
36. Mikolajczak, S.A., Jacobs-Lorena, V., MacKellar, D.C., Camargo, N., and Kappe, S.H. (2007) L-FABP is a critical host factor for successful malaria liver stage development. Int J Parasitol 37: 483-489.
37. Mueller, A.K., Camargo, N., Kaiser, K., Andorfer, C., Frevert, U., Matuschewski, K., and Kappe, S.H. (2005a) Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci USA 102: 3022-3027.
38. Mueller, A.K., Labaied, M., Kappe, S.H., and Matuschewski, K. (2005b) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433: 164-167.
39. Paul, K.S., Bacchi, C.J., and Englund, P.T. (2004) Multiple triclosan targets in Trypanosoma brucei. Eukaryot Cell 3: 855-861.
40. Prudencio, M., Rodriguez, A., and Mota, M.M. (2006) The silent path to thousands of merozoites: The Plasmodium liver stage. Nat Rev Microbiol 4: 849-856.
41. Ralph, S.A., van Dooren, G.G., Waller, R.F., Crawford, M.J., Fraunholz, M.J., Foth, B.J., etal. (2004) Tropical infectious diseases: Metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat Rev Microbiol 2: 203-216.
42. Sato, S., and Wilson, R.J. (2005) The plastid of Plasmodium spp. a target for inhibitors. Curr Top Microbiol Immunol 295: 251-273.
43. Sharma, S., Sharma, S.K., Modak, R., Karmodiya, K., Surolia, N., and Surolia, A. (2007) Mass spectrometry-based systems approach for identification of inhibitors of Plasmodium falciparum fatty acid synthase. Antimicrob Agents Chemother 51: 2552-2558.
44. Sharma, A., Yogavel, M., Akhouri, R.R., Gill, J., and Sharma, A. (2008) Crystal structure of soluble domain of malaria sporozoite protein UIS3 in complex with lipid. J Biol Chem 283: 24077-24088.
45. Shortt, H.E., Fairley, N.H., Covell, G., Shute, P.G., and Garnham, P.C. (1951) The pre-erythrocytic stage of Plasmodium falciparum. Trans R Soc Trop Med Hyg 44: 405-419.
46. Silvie, O., Rubinstein, E., Franetich, J.F., Prenant, M., Belnoue, E., Renia, L., et al. (2003) Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat Med 9: 93-96.
47. Snow, R.W., Guerra, C.A., Noor, A.M., Myint, H.Y., and Hay, S.I. (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217.
48. Suhrbier, A., Holder, A.A., Wiser, M.F., Nicholas, J., and Sinden, R.E. (1989) Expression of the precursor of the major merozoite surface antigens during the hepatic stage of malaria. Am J Trop Med Hyg 40: 351-355.
49. Surolia, A., Ramya, T.N., Ramya, V., and Surolia, N. (2004) 'FAS't inhibition of malaria. Biochem J 383: 401-412.
50. Surolia, N., and Surolia, A. (2001) Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat Med 7: 167-173.
51. Tarun, A.S., Dumpit, R.F., Camargo, N., Labaied, M., Liu, P., Takagi, A., et al. (2007) Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 196: 608-616.
52. Tarun, A.S., Peng, X., Dumpit, R.F., Ogata, Y., Silva-Rivera, H., Camargo, N., et al. (2008) A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 105: 305-310.
53. Tasdemir, D., Lack, G., Brun, R., Ruedi, P., Scapozza, L., and Perozzo, R. (2006) Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J Med Chem 49: 3345-3353.
54. Tsuji, M., Mattei, D., Nussenzweig, R.S., Eichinger, D., and Zavala, F. (1994) Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res 80: 16-21.
55. Vial, H.J., and Ancelin, M.L. (1992) Malarial lipids. An overview. Subcell Biochem 18: 259-306.
56. Waller, R.F., Keeling, P.J., Donald, R.G., Striepen, B., Handman, E., Lang-Unnasch, N., et al. (1998) Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci USA 95: 12352-12357.
57. Wiesner, J., and Seeber, F. (2005) The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs. Expert Opin Ther Targets 9: 23-44.
58. Yeoh, S., O'Donnell, R.A., Koussis, K., Dluzewski, A.R., Ansell, K.H., Osborne, S.A., et al. (2007) Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell 131: 1072-1083.